Arrowhead Pharmaceuticals focuses on developing therapies using RNA interference technology to target genes associated with diseases, particularly those with significant unmet medical needs. self-described as aiming to have numerous products in clinical trials or on the market by 2025.

Arrowhead Pharmaceuticals

BASE mRNA facility focuses on messenger RNA design, manufacturing, and research. They provide end-to-end research services to design, manufacture, and test new mRNA medicines.

BASE mRNA facility

Jaguar Gene Therapy focuses on accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases, according to their self-described mission.

Metric
Company Name	Arrowhead Pharmaceuticals	BASE mRNA facility	Jaguar Gene Therapy
Symbol
MSH ID	COM:ARROWHEADPHARMA	AU:ORG:BASEFACILITY	COM:JAGUARGENETHERAPY
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology	Biotechnology
Country	US	AU	US
Stage	Post-IPO Debt
Employee Count
Website	arrowheadpharma.com	basefacility.org.au	jaguargenetherapy.com
LinkedIn		base-facility
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	15.59K
Web Traffic Growth	0.03
Valuation
Raised Capital	400M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ARROWHEADPHARMA

Arrowhead Pharmaceuticals

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue